Current Immunotherapy Approaches against Skin Cancer

Dear Colleagues,

The advent of immunotherapy has profoundly transformed the landscape of cancer management with a substantial impact on patient care, emphasizing the importance of patient-tailored approaches. This paradigmatic shift brought about by immunotherapy has deeply influenced the management of dermatologic patients, particularly in the melanoma and non-melanoma skin cancer fields, offering breakthroughs in treating advanced stages. Furthermore, ongoing trials highlight the continuous evolution of our understanding of immunotherapy's potential. The evidence supporting the efficacy of immunotherapy is still growing, emphasizing the need for continued investigation and research.

We invite colleagues around the world to report their clinical experience with immunotherapy approaches against melanoma, non-melanoma skin cancer, Merkel cell carcinoma, skin adnexal carcinomas, and soft tissue sarcomas. Clinical contributions regarding immunotherapy approaches in skin cancer management, in the format of case reports, case series, reviews, and clinical studies (retrospective and/or prospective), are welcome for this Special Issue.

Thank you for your contribution.

Kind regards,

Prof. Dr. Mauro Salvatore Alessandro Alaibac
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• skin cancer
• immunotherapy
• immune checkpoint inhibitors
• survival
• melanoma
• non-melanoma skin cancer
• Merkel cell carcinoma
• soft tissue sarcoma